BioMarin Pharmaceutical Inc. buy JPMorgan Chase & Co.
Start price
30.10.24
/
50%
€61.40
Target price
30.10.25
€100.36
Performance (%)
-26.91%
End price
31.10.25
€44.88
Summary
This prediction ended on 31.10.25 with a price of €44.88. The prediction for BioMarin Pharmaceutical Inc. disappointed with a performance of -26.91%. JPMorgan_Chase___Co_ has a follow-up prediction for BioMarin Pharmaceutical Inc. where he still thinks BioMarin Pharmaceutical Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.138% | 5.138% | -19.321% |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target lowered by analysts at JPMorgan Chase & Co. from $110.00 to $109.00. They now have an "overweight" rating on the stock.
Ratings data for BMRN provided by MarketBeat
In the thread Trading BioMarin Pharmaceutical Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€50.32
14.07.25
14.07.25
€96.68
14.07.26
14.07.26
5.72%
24.02.26
24.02.26
Stopped prediction by JPMorgan_Chase___Co_ for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€46.83
09.10.25
09.10.25
€102.23
09.10.26
09.10.26
13.60%
24.02.26
24.02.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€75.46
05.09.24
05.09.24
€108.11
05.09.25
05.09.25
-34.85%
06.09.25
06.09.25